Your browser doesn't support javascript.
Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients.
Chalkias, Athanasios; Mouzarou, Angeliki; Samara, Evangelia; Xanthos, Theodoros; Ischaki, Eleni; Pantazopoulos, Ioannis.
  • Chalkias A; Department of Anesthesiology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larisa, Greece. thanoschalkias@yahoo.gr.
  • Mouzarou A; Department of Cardiology, General Hospital of Paphos, Paphos, Cyprus.
  • Samara E; Department of Anesthesiology, Tzaneio General Hospital, Piraeus, Greece.
  • Xanthos T; School of Medicine, European University Cyprus, Nicosia, Cyprus.
  • Ischaki E; First Department of Critical Care Medicine and Pulmonary Services, Evangelismos Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Pantazopoulos I; Department of Emergency Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larisa, Greece.
Mol Diagn Ther ; 24(5): 517-521, 2020 10.
Article in English | MEDLINE | ID: covidwho-618873
ABSTRACT
The novel coronavirus infection has spread worldwide, causing a wide spectrum of clinical manifestations. Most patients develop moderate clinical illness, but a substantial number will experience severe pneumonia, which may rapidly progress to acute respiratory distress syndrome and multiple organ failure. In this population, soluble urokinase plasminogen activator receptor (suPAR) could serve as a quick triage test and independent marker of clinical severity, hospital and intensive care unit admission, complications, and mortality.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Receptors, Urokinase Plasminogen Activator Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Mol Diagn Ther Journal subject: Molecular Biology / Pharmacology / Laboratory Techniques and procedures Year: 2020 Document Type: Article Affiliation country: S40291-020-00481-8

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Receptors, Urokinase Plasminogen Activator Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Mol Diagn Ther Journal subject: Molecular Biology / Pharmacology / Laboratory Techniques and procedures Year: 2020 Document Type: Article Affiliation country: S40291-020-00481-8